BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30370558)

  • 1. HDAC6 inhibition induces the failure of mouse early embryonic development.
    Wang H; Ling L; Ai L; Bai L
    J Cell Physiol; 2019 Jun; 234(6):8752-8759. PubMed ID: 30370558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
    Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
    Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
    Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
    Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC6 inhibition disrupts maturational progression and meiotic apparatus assembly in mouse oocytes.
    Ling L; Hu F; Ying X; Ge J; Wang Q
    Cell Cycle; 2018; 17(5):550-556. PubMed ID: 28598228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
    Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
    Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-кB signaling pathways.
    Wang J; Zhao L; Wei Z; Zhang X; Wang Y; Li F; Fu Y; Liu B
    Int Immunopharmacol; 2018 Mar; 56():230-234. PubMed ID: 29414656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression.
    Sui L; Huang R; Yu H; Zhang S; Li Z
    J Cell Physiol; 2020 Oct; 235(10):7030-7042. PubMed ID: 32017059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
    Liu Z; Cai Y; Yang Y; Li A; Bi R; Wang L; Shen X; Wang W; Jia Y; Yu B; Cao B; Cui W; Wei P; Zhou X
    J Pathol; 2018 Oct; 246(2):141-153. PubMed ID: 29876933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 inhibitor promotes reactive oxygen species-meditated clearance of Staphylococcus aureus in macrophage.
    Yimiti M; Fei X; Yang H; Yang X; Li S; Tuoheniyazi H; Liu D; Ma J; Xie J; Zheng J; Song Z; Li Q; Xu D; Zhao Y; Gu Z
    Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13866. PubMed ID: 38719209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
    Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
    Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
    Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
    Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
    Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
    Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubastatin A inhibits HDAC and Sirtuin activity rather than being a HDAC6-specific inhibitor in mouse oocytes.
    Choi YJ; Kang MH; Hong K; Kim JH
    Aging (Albany NY); 2019 Mar; 11(6):1759-1777. PubMed ID: 30913540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK/NF-κB pathways.
    Zhang WB; Yang F; Wang Y; Jiao FZ; Zhang HY; Wang LW; Gong ZJ
    Biomed Pharmacother; 2019 Sep; 117():109166. PubMed ID: 31255993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect.
    Messaoudi K; Ali A; Ishaq R; Palazzo A; Sliwa D; Bluteau O; Souquère S; Muller D; Diop KM; Rameau P; Lapierre V; Marolleau JP; Matthias P; Godin I; Pierron G; Thomas SG; Watson SP; Droin N; Vainchenker W; Plo I; Raslova H; Debili N
    Nat Commun; 2017 Nov; 8(1):1786. PubMed ID: 29176689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
    Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
    Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells.
    Urdiciain A; Erausquin E; Meléndez B; Rey JA; Idoate MA; Castresana JS
    Int J Oncol; 2019 May; 54(5):1797-1808. PubMed ID: 30864703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.